Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost vs Fixed Combination Latanoprost/Timolol in Glaucoma
NCT02154217Phase 3Completed
- Sponsor
- University of Milan
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of bimatoprost in primary open-angle glaucoma (POAG) and ocular hypertension (2 arms), sponsored by University of Milan. Primary endpoint: Difference in mean diastolic and systolic perfusion pressures at 12 weeks. Status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02154217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154217.